Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
The phase Ib TROPION-Lung02 trial is a dose-escalation and -expansion study evaluating Dato-DXd (4 or 6 mg/kg) combined with pembrolizumab (doublet) with or without platinum agents (triplet therapy) in both previously untreated and pre-treated patients with metastatic NSCLC without actionable genomic alterations
Complete inhibition (6log 10 reduction) with the use of PTL DC was achieved after 4 h of contact
Keep the compact 30g tube in your bag for convenient midday reapplication
Bai Z, Wang Z
Curcumin prevents cyclophosphamide-induced lung injury in rats by suppressing oxidative stress and apoptosis
doi:10.1146/annurev.pharmtox.45.120403.095857
US$ 28.84
US$ 21.75
US$ 22.34
US$ 29.02
